TOT BIOPHARM International Company Limited
HKEX:1875.HK
2 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 351.6 | 467.102 | 472.412 | 154.876 | 152.805 | 156.243 | 225.533 | 113.509 | 539.18 |
| Short Term Investments
| 6.764 | 0 | 45.222 | 0 | 2.577 | 0 | 2.598 | 241.051 | 32.139 |
| Cash and Short Term Investments
| 351.6 | 467.102 | 517.634 | 154.876 | 152.805 | 156.243 | 225.533 | 354.56 | 571.319 |
| Net Receivables
| 140.705 | 93.757 | 113.107 | 80.595 | 23.687 | 6.466 | 2.438 | 7.961 | 9.191 |
| Inventory
| 126.009 | 118.201 | 106.459 | 56.822 | 29.558 | 19.727 | 8.114 | 11.07 | 15.25 |
| Other Current Assets
| 0.017 | 52.103 | 22.667 | 50.502 | 79.862 | 24.433 | 5.316 | 274.887 | 27.794 |
| Total Current Assets
| 693.175 | 731.162 | 759.867 | 374.632 | 305.963 | 206.869 | 249.227 | 407.427 | 614.363 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 699.229 | 716.307 | 631.891 | 413.9 | 365.832 | 336.368 | 297.748 | 332.744 | 323.889 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 21.475 | 4.306 | 5.218 | 4.859 | 18.451 | 3.102 | 16.903 | 2.839 | 16.411 |
| Goodwill and Intangible Assets
| 21.475 | 4.306 | 5.218 | 4.859 | 18.451 | 3.102 | 16.903 | 2.839 | 16.411 |
| Long Term Investments
| 0 | 3.647 | 3.575 | 0.86 | 1.483 | 8.823 | 8.076 | 9.354 | -24.148 |
| Tax Assets
| 0 | 0 | 0 | 3.383 | 18.363 | 0 | 69.127 | 0 | 86.671 |
| Other Non-Current Assets
| 12.222 | 16.647 | 16.381 | 14.643 | 0.171 | 78.058 | 0.102 | 61.568 | 0.176 |
| Total Non-Current Assets
| 732.926 | 740.907 | 657.065 | 437.645 | 404.3 | 426.351 | 391.956 | 406.505 | 402.999 |
| Total Assets
| 1,426.101 | 1,472.07 | 1,416.932 | 812.277 | 710.263 | 633.22 | 641.183 | 813.932 | 1,017.362 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 35.71 | 45.606 | 29.172 | 76.012 | 28.214 | 21.99 | 18.006 | 0 | 0 |
| Short Term Debt
| 42.772 | 46.17 | 86.508 | 186.624 | 147.654 | 51.725 | 1.323 | 1.645 | 62.775 |
| Tax Payables
| 1.659 | 1.755 | 2.848 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 299.287 | 7.752 | 27.259 | 105.083 | 80.223 | -0.99 | -1.323 | 0 | 0 |
| Other Current Liabilities
| 4.717 | 237.668 | 166.204 | 4.753 | 4.717 | 56.978 | 34.737 | 62.001 | 84.011 |
| Total Current Liabilities
| 382.486 | 337.197 | 309.143 | 372.472 | 260.808 | 129.703 | 52.743 | 63.646 | 146.786 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 302.879 | 310.033 | 238.17 | 60.512 | 60.911 | 22.519 | 6.083 | 6.197 | 12.299 |
| Deferred Revenue Non-Current
| 11 | 0 | 42.368 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0.387 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 43.05 | 60.981 | 11.262 | 51.125 | 53.453 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 356.929 | 371.015 | 292.187 | 111.637 | 114.364 | 22.519 | 6.083 | 6.197 | 12.299 |
| Total Liabilities
| 739.415 | 708.212 | 601.33 | 484.109 | 375.172 | 152.222 | 58.826 | 69.843 | 159.085 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 2,297.499 | 2,478.587 | 2,579.493 | 1,892.906 | 1,892.906 | 1,892.906 | 1,874.438 | 1,874.438 | 1,874.438 |
| Retained Earnings
| -1,683.285 | -1,791.586 | -1,845.603 | -1,611.336 | -1,595.612 | -1,456.589 | -1,341.584 | -1,182.269 | -1,053.086 |
| Accumulated Other Comprehensive Income/Loss
| 72.472 | 76.857 | 67.614 | 46.598 | 37.797 | 44.681 | 49.503 | 51.92 | -93.083 |
| Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 130.008 |
| Total Shareholders Equity
| 686.686 | 763.858 | 801.504 | 328.168 | 335.091 | 480.998 | 582.357 | 744.089 | 858.277 |
| Total Equity
| 686.686 | 763.858 | 803.252 | 328.168 | 335.091 | 480.998 | 582.357 | 744.089 | 858.277 |
| Total Liabilities & Shareholders Equity
| 1,426.101 | 1,472.07 | 1,416.932 | 812.277 | 710.263 | 633.22 | 641.183 | 813.932 | 1,017.362 |